Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
3
×
deals
life sciences
national blog main
new york blog main
new york top stories
biotech
national top stories
san francisco blog main
san francisco top stories
sanofi
acetylon pharmaceuticals
alirocumab
alnylam pharmaceuticals
ambys medicines
amgen
biontech
boehringer ingelheim
boston
cell therapy
clinical trials
constellation pharmaceuticals
curevac
eli lilly
evolocumab
fda
gene therapy
genentech
holger willenbring
inclisiran
infectious diseases
ipo
jeffrey tong
john shiver
juan carlos izpisua belmonte
keith dionne
liver disease
markus grompe
martin burke
What
deal
3
×
medicines
new
3
×
acquire
agreed
aiming
ambys
bets
big
billion
bio
biotech
brings
cancer
cash
cholesterol
comes
companies
company
compound
control
cut
date
deadly
debuted
diseases
drug
effective
enticed
evidence
fda
formed
future
hasn’t
latest
launch
liver
make
medco
messenger
Language
unset
Current search:
deal
×
new
×
" boston top stories "
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
